02242nas a2200469   4500000000100000008004100001260000900042653001500051653001000066653002600076653002400102653001500126653002500141653001000166653002100176653003000197653001100227653001600238653001100254653002100265653001100286653002000297653002300317653001200340653000900352653001600361653002500377653001500402653001700417653000900434653001600443100001400459700001600473700001400489700002200503245013100525856005700656300001000713490001500723520102000738022001401758       2008                            d  c200810aAdolescent10aAdult10aAntibodies, Bacterial10aAntigens, Bacterial10aBiomarkers10aCase-Control Studies10aChild10aChild, Preschool10aDrug Therapy, Combination10aFemale10aGlycolipids10aHumans10aImmunoglobulin M10aInfant10aInfant, Newborn10aLeprostatic Agents10aleprosy10aMale10aMiddle Aged10aMycobacterium leprae10aRecurrence10aRisk Factors10aSkin10aYoung Adult1 aBrito MFM1 aXimenes RAA1 aGallo MEN1 aBührer-Sékula S00aAssociation between leprosy reactions after treatment and bacterial load evaluated using anti PGL-I serology and bacilloscopy.  uhttp://www.scielo.br/pdf/rsbmt/v41s2/en_v41s2a14.pdf  a67-720 v41 Suppl 23 a<p>Leprosy (Hansen's disease, HD) reactions are immune-inflammatory phenomena that occur during the evolution of the disease. Given the current criteria for treatment of the disease, this event is often observed after the patient has been released from treatment (RFT) from multi-drug therapy (MDT). A case-control study was conducted comparing laboratory results of cases of leprosy reactions after RFT from multibacillary MDT (MDT/MB) with a control group to analyze the possible association between posttreatment reactions and bacterial load using the ML Flow serological test for detection of antibodies to Mycobacterium leprae and the results of bacilloscopic skin smears. The study was conducted in two reference centers in Recife, Pernambuco State, Brazil, involving 208 patients. The results obtained indicate that posttreatment reaction is statistically associated with bacterial load through positive serology post-RFT. In conclusion, common risk factors exist between relapses and post-RFT reactions.</p>  a1678-9849